相关实验视频
Updated: Sep 11, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
ARID1A:基因,蛋白质,以及子宫内膜癌中的功能
Savannah E LaBuda1,2, Russell R Broaddus1,2, Andrew B Gladden3,4
1Department of Pathology & Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
在子宫内膜癌中常见的ARID1A蛋白质损失会影响预后和转移. 评估ARID1A蛋白缺失,而不仅仅是突变,对于理解这种疾病至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 在癌症中,ARID1A是SWI/SNF染色体重塑复合体中最常发生突变的子单元.
- 丢失ARID1A蛋白与预后不佳和各种癌症转移的增加有关.
- 子宫内膜癌的发病率和死亡率呈上升趋势,强调需要更好的预后标志物.
研究的目的:
- 审查ARID1A在子宫内膜癌的发病和预后中的作用.
- 突出与ARID1A.A.相关的潜在治疗漏洞.
- 强调需要评估ARID1A蛋白缺失超出突变状态的必要性.
主要方法:
- 关于ARID1A在子宫内膜癌中的研究的文献综述.
- 对ARID1A突变状态和蛋白质表达的现有数据的分析.
- 探索调节ARID1A蛋白水平的替代机制.
主要成果:
- 在子宫内膜癌中,ARID1A突变很常见,但蛋白质损失可以通过其他机制发生.
- 在子宫内膜瘤中观察到ARID1A突变和蛋白质表达之间的不一致.
- ARID1A蛋白质损失与预后不佳和基因组不稳定性相关.
结论:
- 在子宫内膜癌的进展中,ARID1A起着至关重要的作用.
- 仅依靠ARID1A测序可能会错过ARID1A蛋白缺失的患者.
- 评估ARID1A蛋白质状况对于了解子宫内膜癌预后和开发向疗法至关重要.
更多相关视频
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
相关概念视频
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of the Unfolded Protein Response